Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Eduardo Slatopolsky
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Anatomy
Disorders
Living Beings
Procedures
Sign-in to see full Profile
Network (preview)
52
Dusso, Adriana
24
Brown, Alex
20
Brown, AJ
12
Cozzolino, Mario
11
Finch, Jane
10
Finch, Jane
10
Burke, Steven
8
Ritter, Cynthia
8
Morrissey, Jeremiah
6
Lu, Yan
6
Windus, Debra
5
Sato, Tetsuhiko
5
Martin, Daniel
4
Kubodera, Noboru
4
Mizobuchi, Masahide
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Eduardo Slatopolsky (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Martin Kevin J; González Esther A; Slatopolsky Eduardo
Clinical consequences and management of hypomagnesemia.
Journal of the American Society of Nephrology : JASN 2009;20(11):2291-5.
-
2009: Mizobuchi Masahide; Towler Dwight; Slatopolsky Eduardo
Vascular calcification: the killer of patients with chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2009;20(7):1453-64.
-
2009: Mizobuchi Masahide; Ritter Cynthia S; Krits Irina; Slatopolsky Eduardo; Sicard Gregorio; Brown Alex J
Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(7):1173-9.
-
2009: Tokumoto Masanori; Mizobuchi Masahide; Finch Jane L; Nakamura Hironori; Martin Daniel R; Slatopolsky Eduardo
Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
American journal of nephrology 2009;29(6):582-91.
-
2009: Husain Kazim; Ferder Leon; Mizobuchi Masahide; Finch Jane; Slatopolsky Eduardo
Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.
American journal of nephrology 2009;29(5):465-72.
-
2008: Brown Alex J; Slatopolsky Eduardo
Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
Molecular aspects of medicine 2008;29(6):433-52.
-
2008: Arcidiacono Maria Vittoria; Cozzolino Mario; Spiegel Noah; Tokumoto Masanori; Yang Jing; Lu Yan; Sato Tetsuhiko; Lomonte Carlo; Basile Carlo; Slatopolsky Eduardo; Dusso Adriana S
Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism.
Journal of the American Society of Nephrology : JASN 2008;19(10):1919-28.
-
2008: Arcidiacono Maria Vittoria; Sato Tetsuhiko; Alvarez-Hernandez Daniel; Yang Jing; Tokumoto Masanori; Gonzalez-Suarez Ignacio; Lu Yan; Tominaga Yoshihiro; Cannata-Andia Jorge; Slatopolsky Eduardo; Dusso Adriana S
EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
Journal of the American Society of Nephrology : JASN 2008;19(2):310-20.
-
2008: Ritter Cynthia S; Pande Sangeeta; Krits Irina; Slatopolsky Eduardo; Brown Alex J
Destabilization of parathyroid hormone mRNA by extracellular Ca2+ and the calcimimetic R-568 in parathyroid cells: role of cytosolic Ca and requirement for gene transcription.
Journal of molecular endocrinology 2008;40(1):13-21.
-
2007: Mizobuchi M; Finch J L; Martin D R; Slatopolsky E
Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.
Kidney international 2007;72(6):709-15.
-
2007: Mizobuchi Masahide; Morrissey Jeremiah; Finch Jane L; Martin Daniel R; Liapis Helen; Akizawa Tadao; Slatopolsky Eduardo
Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
Journal of the American Society of Nephrology : JASN 2007;18(6):1796-806.
-
2007: Slatopolsky Eduardo; Finch Jane L; Brown Alex J; Ritter Cynthia S; Mizobuchi Masahide; Plum Lori A; Clagett-Dame Margaret; Sicinski Rafal R; DeLuca Hector F
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(5):686-94.
-
2007: Brown Alex J; Slatopolsky Eduardo
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Nature clinical practice. Endocrinology & metabolism 2007;3(2):134-44.
-
2007: Dusso Adriana S; Arcidiacono Maria Vittoria; Sato Tetsuhiko; Alvarez-Hernandez Daniel; Yang Jing; Gonzalez-Suarez Ignacio; Tominaga Yoshihiro; Slatopolsky Eduardo
Molecular basis of parathyroid hyperplasia.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2007;17(1):45-7.
-
2006: Ritter C S; Armbrecht H J; Slatopolsky E; Brown A J
25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
Kidney international 2006;70(4):654-9.
-
2006: Dusso A S; Sato T; Arcidiacono M V; Alvarez-Hernandez D; Yang J; Gonzalez-Suarez I; Tominaga Y; Slatopolsky E
Pathogenic mechanisms for parathyroid hyperplasia.
Kidney international. Supplement 2006;(102):S8-11.
-
2006: Joist H E; Ahya S N; Giles K; Norwood K; Slatopolsky E; Coyne D W
Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.
Clinical nephrology 2006;65(5):335-41.
-
2005: Slatopolsky Eduardo; Liapis Helen; Finch Jane
Progressive accumulation of lanthanum in the liver of normal and uremic rats.
Kidney international 2005;68(6):2809-13.
-
2005: Cozzolino Mario; Lu Yan; Sato Tetsuhiko; Yang Jing; Suarez Ignacio Gonzalez; Brancaccio Diego; Slatopolsky Eduardo; Dusso Adriana S
A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease.
American journal of physiology. Renal physiology 2005;289(5):F1096-102.
-
2005: Martin Daniel R; Ritter Cynthia S; Slatopolsky Eduardo; Brown Alex J
Acute regulation of parathyroid hormone by dietary phosphate.
American journal of physiology. Endocrinology and metabolism 2005;289(4):E729-34.
-
2005: Cozzolino Mario; Brancaccio Diego; Gallieni Maurizio; Slatopolsky Eduardo
Pathogenesis of vascular calcification in chronic kidney disease.
Kidney international 2005;68(2):429-36.
-
2005: Dusso Adriana S; Brown Alex J; Slatopolsky Eduardo
Vitamin D.
American journal of physiology. Renal physiology 2005;289(1):F8-28.
-
2005: Cozzolino Mario; Brancaccio Diego; Gallieni Maurizio; Galassi Andrea; Slatopolsky Eduardo; Dusso Adriana
Pathogenesis of parathyroid hyperplasia in renal failure.
Journal of nephrology 2005;18(1):5-8.
-
2005: Slatopolsky Eduardo; Brown Alex; Dusso Adriana
Calcium, phosphorus and vitamin D disorders in uremia.
Contributions to nephrology 2005;149():261-71.
-
2004: Akizawa Tadao; Ohashi Yasuo; Akiba Takashi; Suzuki Masashi; Nishizawa Yoshiki; Ogata Etsuro; Slatopolsky Eduardo; Kurokawa Kiyoshi
Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(6):480-91.
-
2004: Dusso Adriana; Cozzolino Mario; Lu Yan; Sato Tetsuhiko; Slatopolsky Eduardo
1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.
The Journal of steroid biochemistry and molecular biology 2004;89-90(1-5):507-11.
-
2004: Ritter Cynthia S; Slatopolsky Eduardo; Santoro Samuel; Brown Alex J
Parathyroid cells cultured in collagen matrix retain calcium responsiveness: importance of three-dimensional tissue architecture.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(3):491-8.
-
2004: Dusso Adriana S; Thadhani Ravi; Slatopolsky Eduardo
Vitamin D receptor and analogs.
Seminars in nephrology 2004;24(1):10-6.
-
2003: Cozzolino Mario; Staniforth Mark E; Liapis Helen; Finch Jane; Burke Steven K; Dusso Adriana S; Slatopolsky Eduardo
Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Kidney international 2003;64(5):1653-61.
-
2003: Slatopolsky Eduardo
New developments in hyperphosphatemia management.
Journal of the American Society of Nephrology : JASN 2003;14(9 Suppl 4):S297-9.
-
2003: Slatopolsky Eduardo; Cozzolino Mario; Lu Yan; Finch Jane; Dusso Andriana; Staniforth Marc; Wein Yoo; Webster Jee
Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
Kidney international 2003;63(6):2020-7.
-
2003: Slatopolsky Eduardo; Finch Jane; Brown Alex
New vitamin D analogs.
Kidney international. Supplement 2003;(85):S83-7.
-
2003: Slatopolsky Eduardo; Gonzalez Esther; Martin Kevin
Pathogenesis and treatment of renal osteodystrophy.
Blood purification 2003;21(4-5):318-26.
-
2002: Ritter Cynthia S; Martin Daniel R; Lu Yan; Slatopolsky Eduardo; Brown Alex J
Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(12):2206-13.
-
2002: Coyne Daniel W; Grieff Marvin; Ahya Shubhada N; Giles Karla; Norwood Kathy; Slatopolsky Eduardo
Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(6):1283-8.
-
2002: Slatopolsky Eduardo; Cozzolino Mario; Finch Jane L
Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.
Kidney international 2002;62(4):1277-84.
-
2002: Cordero Julia B; Cozzolino Mario; Lu Yan; Vidal Marcos; Slatopolsky Eduardo; Stahl Philip D; Barbieri M Alejandro; Dusso Adriana
1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor.
The Journal of biological chemistry 2002;277(41):38965-71.
-
2002: Cozzolino Mario; Dusso Adriana S; Liapis Helen; Finch Jane; Lu Yan; Burke Steven K; Slatopolsky Eduardo
The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Journal of the American Society of Nephrology : JASN 2002;13(9):2299-308.
-
2002: Takahashi Fumiaki; Yorozu Keigo; Kawata Yuki; Kitamura Hidetomo; Chiba Nobuyuki; Kubodera Noboru; Slatopolsky Eduardo
[Effects of intravenous and oral OCT on secondary hyperparathyroidism in dogs with chronic renal failure]
Clinical calcium 2002;12(6):741-8.
-
2002: Brown Alex J; Dusso Adriana S; Slatopolsky Eduardo
[Renal failure and vitamin D]
Clinical calcium 2002;12(6):711-23.
-
2002: Brown Alex J; Finch Jane; Slatopolsky Eduardo
Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport.
The Journal of laboratory and clinical medicine 2002;139(5):279-84.
-
2002: Slatopolsky Eduardo; Dusso Adriana; Brown Alex J
Control of uremic bone disease: role of vitamin D analogs.
Kidney international. Supplement 2002;(80):143-8.
-
2002: Takahashi Fumiaki; Denda Masashi; Finch Jane L; Brown Alex J; Slatopolsky Eduardo
Hyperplasia of the parathyroid gland without secondary hyperparathyroidism.
Kidney international 2002;61(4):1332-8.
-
2002: Takahashi Fumiaki; Furuichi Tatsuya; Yorozu Keigo; Kawata Setsu; Kitamura Hidetomo; Kubodera Noboru; Slatopolsky Eduardo
Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():46-52.
-
2002: Hirata Michinori; Endo Koichi; Ohkawa Hiroyuki; Kumaki Kenji; Kubodera Noboru; Slatopolsky Eduardo; Kurokawa Kiyoshi; Fukagawa Masafumi
A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():37-40.
-
2002: Akizawa Tadao; Suzuki Masashi; Akiba Takashi; Nishizawa Yoshiki; Ohashi Yasuo; Ogata Etsuro; Slatopolsky Eduardo; Kurokawa Kiyoshi
Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():28-36.
-
2002: Brown Alex J; Dusso Adriana S; Slatopolsky Eduardo
Vitamin D analogues for secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():10-9.
-
2002: Slatopolsky Eduardo; Brown Alex J
Vitamin D analogs for the treatment of secondary hyperparathyroidism.
Blood purification 2002;20(1):109-12.
-
2001: Cozzolino M; Lu Y; Finch J; Slatopolsky E; Dusso A S
p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.
Kidney international 2001;60(6):2109-17.
-
2001: Ritter C S; Finch J L; Slatopolsky E A; Brown A J
Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor.
Kidney international 2001;60(5):1737-44.
-
2001: Cozzolino M; Dusso A S; Slatopolsky E
Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure.
Journal of the American Society of Nephrology : JASN 2001;12(11):2511-6.
-
2001: Finch J L; Dusso A S; Pavlopoulos T; Slatopolsky E A
Relative potencies of 1,25-(OH)(2)D(3) and 19-Nor-1,25-(OH)(2)D(2) on inducing differentiation and markers of bone formation in MG-63 cells.
Journal of the American Society of Nephrology : JASN 2001;12(7):1468-74.
-
2001: Dusso A S; Pavlopoulos T; Naumovich L; Lu Y; Finch J; Brown A J; Morrissey J; Slatopolsky E
p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth.
Kidney international 2001;59(3):855-65.
-
2001: Slatopolsky E; Brown A; Dusso A
Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(1 Suppl 2):S54-7.
-
2000: Brown A J; Finch J; Takahashi F; Slatopolsky E
Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment.
Journal of the American Society of Nephrology : JASN 2000;11(11):2088-94.
-
2000: Chertow G M; Plone M; Dillon M A; Burke S K; Slatopolsky E
Hyperparathyroidism and dialysis vintage.
Clinical nephrology 2000;54(4):295-300.
-
2000: Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
A novel mechanism for skeletal resistance in uremia.
Kidney international 2000;58(2):753-61.
-
1999: Slatopolsky E; Dusso A; Brown A
New analogs of vitamin D3.
Kidney international. Supplement 1999;73():S46-51.
-
1999: Slatopolsky E; Brown A; Dusso A
Pathogenesis of secondary hyperparathyroidism.
Kidney international. Supplement 1999;73():S14-9.
-
1999: Chertow G M; Burke S K; Dillon M A; Slatopolsky E
Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(12):2907-14.
-
1999: Brown A J; Dusso A; Slatopolsky E
Vitamin D.
The American journal of physiology 1999;277(2 Pt 2):F157-75.
-
1999: Brown A J; Slatopolsky E
Vitamin D analogs: perspectives for treatment.
Mineral and electrolyte metabolism 1999;25(4-6):337-41.
-
1999: Slatopolsky E; Dusso A; Brown A J
The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
The American journal of the medical sciences 1999;317(6):370-6.
-
1999: Finch J L; Brown A J; Slatopolsky E
Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
Journal of the American Society of Nephrology : JASN 1999;10(5):980-5.
-
1999: Brown A J; Ritter C S; Finch J L; Slatopolsky E A
Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.
Kidney international 1999;55(4):1284-92.
-
1999: Bleyer A J; Burke S K; Dillon M; Garrett B; Kant K S; Lynch D; Rahman S N; Schoenfeld P; Teitelbaum I; Zeig S; Slatopolsky E
A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(4):694-701.
-
1999: Brown A J; Ritter C; Slatopolsky E; Muralidharan K R; Okamura W H; Reddy G S
1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
Journal of cellular biochemistry 1999;73(1):106-13.
-
1999: Monier-Faugere M C; Geng Z; Friedler R M; Qi Q; Kubodera N; Slatopolsky E; Malluche H H
22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
Kidney international 1999;55(3):821-32.
-
1999: Huang Z; Ritter C; Brown A; Finch J; Abu-Amer Y; Ross P; Slatopolsky E
Cloning and localization of Rab3 isoforms in bovine, rat, and human parathyroid glands.
Biochemical and biophysical research communications 1999;255(3):645-51.
-
1999: Chertow G M; Dillon M; Burke S K; Steg M; Bleyer A J; Garrett B N; Domoto D T; Wilkes B M; Wombolt D G; Slatopolsky E
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
Clinical nephrology 1999;51(1):18-26.
-
1999: Slatopolsky E A; Burke S K; Dillon M A
RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.
Kidney international 1999;55(1):299-307.
-
1998: Slatopolsky E; Finch J; Ritter C; Takahashi F
Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(2 Suppl 2):S40-7.
-
1998: Goldberg D I; Dillon M A; Slatopolsky E A; Garrett B; Gray J R; Marbury T; Weinberg M; Wombolt D; Burke S K
Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(9):2303-10.
-
1998: Slatopolsky E
The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13 Suppl 3():3-8.
-
1997: Burke S K; Slatopolsky E A; Goldberg D I
RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(8):1640-4.
-
1997: Dusso A S; Kamimura S; Gallieni M; Zhong M; Negrea L; Shapiro S; Slatopolsky E
gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses.
The Journal of clinical endocrinology and metabolism 1997;82(7):2222-32.
-
1997: Takahashi F; Finch J L; Denda M; Dusso A S; Brown A J; Slatopolsky E
A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;30(1):105-12.
-
1997: Chertow G M; Burke S K; Lazarus J M; Stenzel K H; Wombolt D; Goldberg D; Bonventre J V; Slatopolsky E
Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(1):66-71.
-
1997: Slatopolsky E; Brown A J
Vitamin D and its analogs in chronic renal failure.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7 Suppl 3():S202-8.
-
1996: Denda M; Finch J; Slatopolsky E
Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(4):596-602.
-
1996: Grieff M; Zhong M; Finch J; Ritter C S; Slatopolsky E; Brown A J
Renal calcitriol synthesis and serum phosphorus in response to dietary phosphorus restriction and anabolic agents.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(4):589-95.
-
1996: Denda M; Finch J; Brown A J; Nishii Y; Kubodera N; Slatopolsky E
1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats.
Kidney international 1996;50(1):34-9.
-
1996: Wu S; Finch J; Zhong M; Slatopolsky E; Grieff M; Brown A J
Expression of the renal 25-hydroxyvitamin D-24-hydroxylase gene: regulation by dietary phosphate.
The American journal of physiology 1996;271(1 Pt 2):F203-8.
-
1996: Slatopolsky E; Finch J; Denda M; Ritter C; Zhong M; Dusso A; MacDonald P N; Brown A J
Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.
The Journal of clinical investigation 1996;97(11):2534-40.
-
1996: Brown A J; Zhong M; Finch J; Ritter C; McCracken R; Morrissey J; Slatopolsky E
Rat calcium-sensing receptor is regulated by vitamin D but not by calcium.
The American journal of physiology 1996;270(3 Pt 2):F454-60.
-
1996: Delmez J A; Kelber J; Norword K Y; Giles K S; Slatopolsky E
Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study.
Kidney international 1996;49(1):163-7.
-
1996: Slatopolsky E; Delmez J A
Pathogenesis of secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 3():130-5.
-
1995: Slatopolsky E; Finch J; Ritter C; Denda M; Morrissey J; Brown A; DeLuca H
A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(5):852-60.
-
1995: Negrea L A; Slatopolsky E; Dusso A S
1,25-Dihydroxyvitamin D synthesis in rat liver microsomes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1995;27(10):461-4.
-
1995: Kamimura S; Gallieni M; Zhong M; Beron W; Slatopolsky E; Dusso A
Microtubules mediate cellular 25-hydroxyvitamin D3 trafficking and the genomic response to 1,25-dihydroxyvitamin D3 in normal human monocytes.
The Journal of biological chemistry 1995;270(38):22160-6.
-
1995: Kohrt W M; Snead D B; Slatopolsky E; Birge S J
Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(9):1303-11.
-
1995: Brown A J; Zhong M; Ritter C; Brown E M; Slatopolsky E
Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression.
Biochemical and biophysical research communications 1995;212(3):861-7.
-
1995: Brown A J; Zhong M; Finch J; Ritter C; Slatopolsky E
The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Endocrinology 1995;136(4):1419-25.
-
1995: Gallieni M; Kamimura S; Ahmed A; Bravo E; Delmez J; Slatopolsky E; Dusso A
Kinetics of monocyte 1 alpha-hydroxylase in renal failure.
The American journal of physiology 1995;268(4 Pt 2):F746-53.
-
1995: Delmez J A; Dusso A S; Slatopolsky E; Teitelbaum S L
Modulation of renal osteodystrophy by extrarenal production of calcitriol.
American journal of nephrology 1995;15(1):85-9.
-
1995: Slatopolsky E; Delmez J A
Pathogenesis of secondary hyperparathyroidism.
Mineral and electrolyte metabolism 1995;21(1-3):91-6.
-
1994: Kelber J; Slatopolsky E; Delmez J A
Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;24(3):453-60.
-
1994: Brown A J; Dusso A; Slatopolsky E
Selective vitamin D analogs and their therapeutic applications.
Seminars in nephrology 1994;14(2):156-74.
-
1994: Dusso A; Brown A; Slatopolsky E
Extrarenal production of calcitriol.
Seminars in nephrology 1994;14(2):144-55.
-
1994: MacDonald P N; Ritter C; Brown A J; Slatopolsky E
Retinoic acid suppresses parathyroid hormone (PTH) secretion and PreproPTH mRNA levels in bovine parathyroid cell culture.
The Journal of clinical investigation 1994;93(2):725-30.
-
1993: Kamimura S; Gallieni M; Kubodera N; Nishii Y; Brown A J; Slatopolsky E; Dusso A
Differential catabolism of 22-oxacalcitriol and 1,25-dihydroxyvitamin D3 by normal human peripheral monocytes.
Endocrinology 1993;133(6):2719-23.
-
1993: Brown A J; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.
Endocrinology 1993;133(3):1158-64.
-
1993: Negrea L; Slatopolsky E; Dusso A
Lower affinity for substrate for extrarenal synthesis of calcitriol in chronic uremia.
Kidney international 1993;44(1):134-8.
-
1993: Finch J L; Brown A J; Kubodera N; Nishii Y; Slatopolsky E
Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism.
Kidney international 1993;43(3):561-6.
-
1992: Brown A J; Berkoben M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
Metabolism of 22-oxacalcitriol by a vitamin D-inducible pathway in cultured parathyroid cells.
Biochemical and biophysical research communications 1992;189(2):759-64.
-
1992: Slatopolsky E; Berkoben M; Kelber J; Brown A; Delmez J
Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism.
Kidney international. Supplement 1992;38():S43-9.
-
1992: Finch J L; Brown A J; Mori T; Nishii Y; Slatopolsky E
Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(7):835-9.
-
1992: Delmez J A; Tindira C A; Windus D W; Norwood K Y; Giles K S; Nighswander T L; Slatopolsky E
Calcium acetate as a phosphorus binder in hemodialysis patients.
Journal of the American Society of Nephrology : JASN 1992;3(1):96-102.
-
1992: Dusso A S; Negrea L; Finch J; Kamimura S; Lopez-Hilker S; Mori T; Nishii Y; Brown A; Slatopolsky E
The effect of 22-oxacalcitriol on serum calcitriol.
Endocrinology 1992;130(6):3129-34.
-
1992: Lopez-Hilker S; Martin K J; Sugimoto T; Slatopolsky E
Biologic activities of parathyroid hormone (1-34) and parathyroid hormone-related peptide (1-34) in isolated perfused rat femur.
The Journal of laboratory and clinical medicine 1992;119(6):738-43.
-
1992: Grieff M; Dusso A; Mori T; Nishii Y; Slatopolsky E; Brown A J
22-oxacalcitriol suppresses 25-hydroxycholecalciferol-1 alpha-hydroxylase in rat kidney.
Biochemical and biophysical research communications 1992;185(1):191-6.
-
1992: Delmez J A; Slatopolsky E
Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1992;19(4):303-17.
-
1992: Finch J L; Rapp N; Martin K J; Slatopolsky E
A new sensitive homologous radioimmunoassay for amino-terminal parathyroid hormone in the rat.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(2):229-33.
-
1992: Brown A J; Berkoben M; Ritter C S; Slatopolsky E
Binding and metabolism of 1,25-dihydroxyvitamin D3 in cultured bovine parathyroid cells.
Endocrinology 1992;130(1):276-81.
-
1991: Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown A J
The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Endocrinology 1991;129(2):778-84.
-
1991: Slatopolsky E; Delmez J
Alteration of mineral metabolism in chronic renal failure.
Transplantation proceedings 1991;23(2):1816-7.
-
1991: Dusso A S; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown A J
On the mechanisms for the selective action of vitamin D analogs.
Endocrinology 1991;128(4):1687-92.
-
1991: Dusso A S; Finch J; Brown A; Ritter C; Delmez J; Schreiner G; Slatopolsky E
Extrarenal production of calcitriol in normal and uremic humans.
The Journal of clinical endocrinology and metabolism 1991;72(1):157-64.
-
1991: Nishii Y; Abe J; Mori T; Brown A J; Dusso A S; Finch J; Lopez-Hilker S; Morrissey J; Slatopolsky E
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
Contributions to nephrology 1991;91():123-8.
-
1990: Lopez-Hilker S; Dusso A S; Rapp N S; Martin K J; Slatopolsky E
Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol.
The American journal of physiology 1990;259(3 Pt 2):F432-7.
-
1990: Dusso A; Finch J; Delmez J; Rapp N; Lopez-Hilker S; Brown A; Slatopolsky E
Extrarenal production of calcitriol.
Kidney international. Supplement 1990;29():S36-40.
-
1990: Brown A J; Finch J L; Lopez-Hilker S; Dusso A; Ritter C; Pernalete N; Slatopolsky E
New active analogues of vitamin D with low calcemic activity.
Kidney international. Supplement 1990;29():S22-7.
-
1990: Slatopolsky E; Lopez-Hilker S; Delmez J; Dusso A; Brown A; Martin K J
The parathyroid-calcitriol axis in health and chronic renal failure.
Kidney international. Supplement 1990;29():S41-7.
-
1990: Slatopolsky E; Lopez-Hilker S; Dusso A; Brown A; Delmez J; Martin K
Renal osteodystrophy: past and future.
Contributions to nephrology 1990;78():38-45; discussion 45-6.
-
1990: Sugimoto T; Ritter C; Slatopolsky E; Morrissey J
Role of guanine nucleotide binding protein, cytosolic calcium and cAMP in fluoride-induced suppression of PTH secretion.
Mineral and electrolyte metabolism 1990;16(4):224-31.
-
1989: Slatopolsky E; Weerts C; Norwood K; Giles K; Fryer P; Finch J; Windus D; Delmez J
Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism.
Kidney international 1989;36(5):897-903.
-
1989: Brown A J; Ritter C R; Finch J L; Morrissey J; Martin K J; Murayama E; Nishii Y; Slatopolsky E
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
The Journal of clinical investigation 1989;84(3):728-32.
-
1989: Sugimoto T; Brown A J; Ritter C; Morrissey J; Slatopolsky E; Martin K J
Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells.
Endocrinology 1989;125(2):638-41.
-
1989: Delmez J; Weerts C; Lewis-Finch J; Windus D; Slatopolsky E
Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1989;13(4):308-11.
-
1989: Delmez J A; Tindira C; Grooms P; Dusso A; Windus D W; Slatopolsky E
Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.
The Journal of clinical investigation 1989;83(4):1349-55.
-
1989: Dusso A; Lopez-Hilker S; Lewis-Finch J; Grooms P; Brown A; Martin K; Slatopolsky E
Metabolic clearance rate and production rate of calcitriol in uremia.
Kidney international 1989;35(3):860-4.
-
1989: Brown A J; Dusso A; Lopez-Hilker S; Lewis-Finch J; Grooms P; Slatopolsky E
1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs.
Kidney international 1989;35(1):19-23.
-
1989: Sugimoto T; Civitelli R; Ritter C; Slatopolsky E; Morrissey J
Regulation of cytosolic pH in bovine parathyroid cells: effect of fluoride.
Endocrinology 1989;124(1):149-56.
-
1988: Dusso A; Lopez-Hilker S; Rapp N; Slatopolsky E
Extra-renal production of calcitriol in chronic renal failure.
Kidney international 1988;34(3):368-75.
-
1988: Sugimoto T; Ritter C; Slatopolsky E; Morrissey J
Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in cultured bovine parathyroid cells.
Endocrinology 1988;122(6):2387-92.
-
1988: Sugimoto T; Ritter C; Ried I; Morrissey J; Slatopolsky E
Effect of 1,25-dihydroxyvitamin D3 on cytosolic calcium in dispersed parathyroid cells.
Kidney international 1988;33(4):850-4.
-
1988: Slatopolsky E; Lopez-Hilker S; Dusso A; Morrissey J J; Martin K J
Parathyroid hormone secretion: perturbations in chronic renal failure.
Contributions to nephrology 1988;64():16-24.
-
1987: Galceran T; Martin K J; Morrissey J J; Slatopolsky E
Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
Kidney international 1987;32(6):801-7.
-
1987: Galceran T; Slatopolsky E; Martin K J
Differences in the response to intact b-PTH I-84 and synthetic b-PTH I-34 in isolated perfused bones from young and adult dogs.
Calcified tissue international 1987;41(5):290-2.
-
1987: Pacifici R; Rifas L; Teitelbaum S; Slatopolsky E; McCracken R; Bergfeld M; Lee W; Avioli L V; Peck W A
Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(13):4616-20.
-
1987: Galceran T; Finch J; Bergfeld M; Coburn J; Martin K; Teitelbaum S; Slatopolsky E
Biological effects of aluminum on normal dogs: studies on the isolated perfused bone.
Endocrinology 1987;121(1):406-13.
-
1987: Martin K J; Finch J L; Hruska K; Slatopolsky E
Effect of biological activity of PTH on its peripheral metabolism in the rat.
Kidney international 1987;31(4):937-40.
-
1986: Slatopolsky E; Weerts C; Stokes T; Windus D; Delmez J
Alternative phosphate binders in dialysis patients: calcium carbonate.
Seminars in nephrology 1986;6(4 Suppl 1):35-41.
-
1986: Lopez-Hilker S; Galceran T; Chan Y L; Rapp N; Martin K J; Slatopolsky E
Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.
The Journal of clinical investigation 1986;78(4):1097-102.
-
1986: Finch J L; Bergfeld M; Martin K J; Chan Y L; Teitelbaum S; Slatopolsky E
The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia.
Kidney international 1986;30(3):318-24.
-
1986: Slatopolsky E; Weerts C; Lopez-Hilker S; Norwood K; Zink M; Windus D; Delmez J
Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis.
The New England journal of medicine 1986;315(3):157-61.
-
1986: Arbelaez M; Olgaard K; Schwartz J; Martin K; Klahr S; Slatopolsky E
Differential biological effects of calcitonin and parathyroid hormone on isolated perfused bone.
Mineral and electrolyte metabolism 1986;12(2):92-7.
-
1985: Olgaard K; Schwartz J; Arbelaez M; Slatopolsky E
Impaired skeletal response to parathyroid hormone in uremia: the role of phosphorus.
Contributions to nephrology 1985;49():32-7.
-
1984: Galceran T; Lewis-Finch J; Martin K J; Slatopolsky E
Absence of biological effects of oxidized parathyroid hormone-(1-34) in dogs and rats.
Endocrinology 1984;115(6):2375-8.
-
1984: Olgaard K; Finco D; Schwartz J; Arbelaez M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia.
Kidney international 1984;26(6):791-7.
-
1983: Korkor A; Martin K J; Olgaard K; Bergfeld M; Teitelbaum S; Klahr S; Slatopolsky E
Altered adenosine 3',5'-monophosphate release in response to parathyroid hormone by isolated perfused bone from glucocorticoid-treated dogs.
Endocrinology 1983;113(2):625-31.
-
1983: Rothstein M; Olgaard K; Arbelaez M; Finco D; Klahr S; Slatopolsky E
Lack of influence of 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion from normal or hyperplastic glands.
Calcified tissue international 1983;35(4-5):449-54.
-
1983: Korkor A; Schwartz J; Bergfeld M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function.
The Journal of clinical endocrinology and metabolism 1983;56(3):496-500.
-
1982: Olgaard K; Schwartz J; Finco D; Arbelaez M; Korkor A; Martin K; Klahr S; Slatopolsky E
Extraction of parathyroid hormone and release of adenosine 3',5'-monophosphate by isolated perfused bones obtained from dogs with acute uremia.
Endocrinology 1982;111(5):1678-82.
-
1982: Olgaard K; Arbelaez M; Schwartz J; Klahr S; Slatopolsky E
Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia.
Calcified tissue international 1982;34(4):403-7.
-
1982: Olgaard K; Schwartz J; Finco D; Arbelaez M; Haddad J; Avioli L; Klahr S; Slatopolsky E
Extraction of vitamin D metabolites by bones of normal adult dogs.
The Journal of clinical investigation 1982;69(3):684-90.
Sign-in to see more
